John L. Dzuris
John L Dzuris received his B.S. degree in Microbiology in 1983 from the Ohio State University, and in 1987 received his M.S. degree in Microbiology from Louisiana State University. He then attended Temple University School of Medicine in Philadelphia, PA receiving his Ph.D. in 1994 in the Department of Microbiology and Immunology, concentrating his studies on retroviral escape from host immune responses. His postdoctoral training continued his study of retroviral and host immune response interactions which was completed at the University of Pennsylvania School of Medicine in Philadelphia, PA in the Department of Microbiology. John then joined the staff at Epimmune, Inc. in San Diego, CA in 1998 where he worked to develop DNA and peptide based vaccines for oncology and infectious diseases as well as determined similarities existing between human and non-human primate immune responses for use as a model for pre-clinical evaluation of vaccine efficacy. In 2001, he joined the staff at Wyeth Corporation as a Senior Scientist in the Department of Viral Immunology in Pearl River, NY conducting viral vaccine discovery research. John was then recruited to join Genzyme Corporation in 2002 as a Senior Scientist to help discover and develop vaccines for oncology and infectious diseases. Spending nearly 10 years at Genzyme, John lead the Cellular Immunology group as an Associate Director in Discovery Research identifying biotherapeutics and small molecule drugs for oncology, transplant, and autoimmune disease. He is currently Head of the Immunology Lab at ImmusanT, Inc. in Cambridge, MA evaluating immune responses to a potentially tolerizing peptide-based immunotherapeutic vaccine for Celiac Disease.
Biography Updated on 11 December 2012